Calcium-permeable AMPA receptors in neonatal hypoxic-ischemic encephalopathy (Review)

Xiao-Juan Tang1, Feng Xing1

  • 1Department of Neonatology, Children's Hospital Affiliated to Soochow University, Suzhou, Jiangsu 215003, P.R. China.

Biomedical Reports
|March 21, 2014
PubMed

Insights

Hypoxic-ischemic encephalopathy (HIE) causes newborn brain injury. This review highlights calcium-permeable α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) as key players in HIE brain damage.

Area of Science:

  • Neuroscience
  • Neonatal Medicine
  • Pathophysiology

Background:

  • Hypoxic-ischemic encephalopathy (HIE) is a significant cause of neonatal brain injury with severe long-term effects.
  • Excitotoxicity, driven by excessive glutamate receptor (GluR) stimulation, is a primary mechanism of neuronal death during ischemia.
  • While N-methyl-D-aspartic acid (NMDA) receptors were initially implicated, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) are now recognized as critical mediators in HIE.

Purpose of the Study:

  • To review the critical role of calcium-permeable AMPARs (Ca²⁺-AMPARs) in the pathogenesis of HIE.
  • To explore the potential of targeting Ca²⁺-AMPARs for neuroprotective strategies in HIE.

Main Methods:

  • Literature review focusing on the involvement of Ca²⁺-AMPARs in HIE.
  • Analysis of studies investigating the mechanisms of AMPAR-mediated neurotoxicity in neonatal hypoxia-ischemia.

Main Results:

  • Ca²⁺-AMPARs play a central role in the selective and delayed neuronal death observed in HIE.
  • Excessive activation of Ca²⁺-AMPARs contributes significantly to brain damage following hypoxic-ischemic insults.

Conclusions:

  • Ca²⁺-permeable AMPARs are crucial mediators of neuronal injury in HIE.
  • Targeting Ca²⁺-AMPARs presents a promising therapeutic avenue for neuroprotection in newborns with HIE.